Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > VAPO Vapotherm > Key Indicators
VAPO Vapotherm
1.378
+0.488+54.83%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
50.27% 215.8029 100.98% 204.6242 79.29% 193.7025 79.29% 193.7025
Receivable Turnover(T)
22.47% 12.2125 -19.76% 8.7061 -16.88% 6.5873 -16.88% 6.5873
Inventory Turnover(T)
-33.18% 1.7153 -52.08% 1.8064 -50.71% 2.13 -50.71% 2.13
Fixed Assets Turnover(T)
-42.88% 3.0748 -46.68% 3.2777 -31.81% 3.9043 -31.81% 3.9043
Total Asset Rate(T)
-5.47% 0.6144 -41.20% 0.5523 -21.45% 0.603 -21.45% 0.603
ROIC
-121.20% -74.365% -25.10% -46.160% -12.83% -39.942% -12.83% -39.942%
ROE
-270.29% -182.764% -38.74% -89.891% -7.80% -66.234% -7.80% -66.234%
ROA
-111.26% -63.247% -19.80% -38.930% -1.22% -31.830% -1.22% -31.830%
Efficiency Ratios
ROA 5 Year Average
-- -- -- -- 15.48% -46.898% -- --
Profitability Ratios TTM
Gross Margin
-23.08% 38.830% -16.26% 42.797% -6.37% 46.948% -6.37% 46.948%
Operating Margin
-87.90% -75.269% -126.67% -65.268% -46.39% -50.080% -46.39% -50.080%
Net Margin
-123.49% -102.944% -103.75% -70.494% -28.86% -52.784% -28.86% -52.784%
EBITDA Margin
-133.80% -0.9093% -120.80% -0.6157% -36.36% -0.4558% -36.36% -0.4558%
R & D Expense Ratio
41.96% 21.890% 39.41% 18.570% 20.46% 16.250% 20.46% 16.250%
Sales Expense Ratio
20.72% 61.710% 22.86% 58.050% 2.57% 53.080% 2.57% 53.080%
Administration Expense Rate
27.18% 30.510% 62.78% 31.450% 44.82% 27.690% 44.82% 27.690%
Financial Health Ratios
Long-Term Debt to Equity Ratio
1,569.79% 741.793% 341.11% 178.922% 50.09% 67.624% 50.09% 67.624%
Total Assets to Common Equity
427.14% 983.616% 87.52% 334.800% 26.83% 240.126% 26.83% 240.126%
Debt to Asset Ratio
1,557.15% 756.977% 338.80% 182.733% 72.64% 80.166% 72.64% 80.166%
Current Ratio
14.29% 5.2873 6.88% 5.3734 -34.16% 2.5421 -34.16% 2.5421
Quick Ratio
-9.73% 3.0193 -7.74% 3.5382 -51.81% 1.5747 -51.81% 1.5747
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- -25.82% 38.789% -- --
Revenue CAGR(5Y)
-- -- -- -- -- 30.336% -- --
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. Its products include Precision Flow, Precision Flow Heliox, Oxygen Assist Module, Nitric Oxidie Disposable Patient Circuit, Tracheostomy Adapter, and Aerogen Adapter. The company was founded by William F. Niland, Jun Cortez, and William Cirksena in 1998 and is headquartered in Exeter, NH.
CEO: Mr. Joseph Army
Market: NYSE
Listing Date: 11/14/2018
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist